Penn Surgeons: Hep C Drugs Make More Kidneys Safe for Transplant
David Greenberg and Peter Reese of the Perelman School of Medicine are highlighted for conducting a pilot study of patients receiving a new Hepatitis C drug.
・ From Philadelphia Inquirer